XTL-6001

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameXTL-6001
Drug Alias NameXTL6001XTL-6001
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucagon receptor agonistsProto-oncogene Mas agonists
TargetsGlucagon-like peptide 1 receptorGlucagon receptorProto-oncogene Mas
Therapy Area/IndicationsOverweightObesityProteinuria +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Xizaili Biomedical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Xizaili Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesityProteinuria +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A